Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 188

1.

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study.

Pettus J, Roussel R, Liz Zhou F, Bosnyak Z, Westerbacka J, Berria R, Jimenez J, Eliasson B, Hramiak I, Bailey T, Meneghini L.

Diabetes Ther. 2019 Feb 14. doi: 10.1007/s13300-019-0568-8. [Epub ahead of print]

PMID:
30767173
2.

Severe Chronic Kidney Disease Is Associated with a Lower Efficiency of Bariatric Surgery.

Hansel B, Arapis K, Kadouch D, Ledoux S, Coupaye M, Msika S, Vrtovsnik F, Marre M, Boutten A, Cherifi B, Cambos S, Beslay M, Courie R, Roussel R.

Obes Surg. 2019 Jan 26. doi: 10.1007/s11695-019-03703-z. [Epub ahead of print]

PMID:
30685835
3.

Letter by Potier and Roussel Regarding Article, "Are We Ready to Bell the Cat? A Call for Cardiologists to Embrace Glucose-Lowering Therapies Proven to Improve Cardiovascular Outcomes".

Potier L, Roussel R.

Circulation. 2019 Jan 8;139(2):303-304. doi: 10.1161/CIRCULATIONAHA.118.037118. No abstract available.

PMID:
30615503
4.

Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individuals.

Hyafil F, Chequer R, Sorbets E, Estellat C, Ducrocq G, Rouzet F, Alfaiate T, Regaieg H, Abtan J, Leygnac S, Milliner M, Imbert L, Burg S, Ben Azzouna R, Potier L, Laouénan C, Quintin C, Roussel R, Hartemann A, Montalescot G, Marie PY, Steg G, Le Guludec D.

J Nucl Cardiol. 2018 Dec 20. doi: 10.1007/s12350-018-01557-z. [Epub ahead of print]

PMID:
30574676
5.

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.

Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, van der Schouw YT, Selmer R, Khaw KT, Gudnason V, Assmann G, Amouyel P, Salomaa V, Kivimaki M, Nordestgaard BG, Blaha MJ, Kuller LH, Brenner H, Gillum RF, Meisinger C, Ford I, Knuiman MW, Rosengren A, Lawlor DA, Völzke H, Cooper C, Marín Ibañez A, Casiglia E, Kauhanen J, Cooper JA, Rodriguez B, Sundström J, Barrett-Connor E, Dankner R, Nietert PJ, Davidson KW, Wallace RB, Blazer DG, Björkelund C, Donfrancesco C, Krumholz HM, Nissinen A, Davis BR, Coady S, Whincup PH, Jørgensen T, Ducimetiere P, Trevisan M, Engström G, Crespo CJ, Meade TW, Visser M, Kromhout D, Kiechl S, Daimon M, Price JF, Gómez de la Cámara A, Wouter Jukema J, Lamarche B, Onat A, Simons LA, Kavousi M, Ben-Shlomo Y, Gallacher J, Dekker JM, Arima H, Shara N, Tipping RW, Roussel R, Brunner EJ, Koenig W, Sakurai M, Pavlovic J, Gansevoort RT, Nagel D, Goldbourt U, Barr ELM, Palmieri L, Njølstad I, Sato S, Monique Verschuren WM, Varghese CV, Graham I, Onuma O, Greenland P, Woodward M, Ezzati M, Psaty BM, Sattar N, Jackson R, Ridker PM, Cook NR, D'Agostino RB, Thompson SG, Danesh J, Di Angelantonio E; Emerging Risk Factors Collaboration .

Eur Heart J. 2019 Feb 14;40(7):621-631. doi: 10.1093/eurheartj/ehy653.

6.

Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I Study.

Roussel R, Duran-García S, Zhang Y, Shah S, Darmiento C, Shankar RR, Golm GT, Lam RLH, O'Neill EA, Gantz I, Kaufman KD, Engel SS.

Diabetes Obes Metab. 2018 Nov 4. doi: 10.1111/dom.13574. [Epub ahead of print]

PMID:
30393950
7.

Lower extremity arterial disease in patients with diabetes: a contemporary narrative review.

Nativel M, Potier L, Alexandre L, Baillet-Blanco L, Ducasse E, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K.

Cardiovasc Diabetol. 2018 Oct 23;17(1):138. doi: 10.1186/s12933-018-0781-1. Review.

8.

Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study.

Fraty M, Velho G, Gand E, Fumeron F, Ragot S, Sosner P, Mohammedi K, Gellen B, Saulnier PJ, Halimi JM, Montaigne D, Ducrocq G, Rehman M, Marre M, Roussel R, Hadjadj S; SURDIAGENE Study Group.

Diabetologia. 2018 Dec;61(12):2643-2653. doi: 10.1007/s00125-018-4727-7. Epub 2018 Sep 19.

PMID:
30232509
9.

GPS2 Deficiency Triggers Maladaptive White Adipose Tissue Expansion in Obesity via HIF1A Activation.

Drareni K, Ballaire R, Barilla S, Mathew MJ, Toubal A, Fan R, Liang N, Chollet C, Huang Z, Kondili M, Foufelle F, Soprani A, Roussel R, Gautier JF, Alzaid F, Treuter E, Venteclef N.

Cell Rep. 2018 Sep 11;24(11):2957-2971.e6. doi: 10.1016/j.celrep.2018.08.032.

10.

More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial.

Rosenstock J, Cheng A, Ritzel R, Bosnyak Z, Devisme C, Cali AMG, Sieber J, Stella P, Wang X, Frías JP, Roussel R, Bolli GB.

Diabetes Care. 2018 Oct;41(10):2147-2154. doi: 10.2337/dc18-0559. Epub 2018 Aug 13.

PMID:
30104294
11.

Prognostic Values of Inflammatory and Redox Status Biomarkers on the Risk of Major Lower-Extremity Artery Disease in Individuals With Type 2 Diabetes.

Nativel M, Schneider F, Saulnier PJ, Gand E, Ragot S, Meilhac O, Rondeau P, Burillo E, Cournot M, Potier L, Velho G, Marre M, Roussel R, Rigalleau V, Mohammedi K, Hadjadj S.

Diabetes Care. 2018 Oct;41(10):2162-2169. doi: 10.2337/dc18-0695. Epub 2018 Aug 2.

PMID:
30072406
12.

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.

Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, Fumeron F, Potier L, Marre M, Hadjadj S, Roussel R.

Cardiovasc Diabetol. 2018 Aug 2;17(1):110. doi: 10.1186/s12933-018-0753-5.

13.

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.

Natividad JM, Agus A, Planchais J, Lamas B, Jarry AC, Martin R, Michel ML, Chong-Nguyen C, Roussel R, Straube M, Jegou S, McQuitty C, Le Gall M, da Costa G, Lecornet E, Michaudel C, Modoux M, Glodt J, Bridonneau C, Sovran B, Dupraz L, Bado A, Richard ML, Langella P, Hansel B, Launay JM, Xavier RJ, Duboc H, Sokol H.

Cell Metab. 2018 Nov 6;28(5):737-749.e4. doi: 10.1016/j.cmet.2018.07.001. Epub 2018 Jul 26.

PMID:
30057068
14.

Bariatric surgery and chronic kidney disease: much hope, but proof is still awaited.

Arapis K, Kadouch D, Cailliéret O, Roussel R, Hansel B.

Int J Obes (Lond). 2018 Aug;42(8):1532-1533. doi: 10.1038/s41366-018-0146-6. Epub 2018 Jul 17. No abstract available.

PMID:
30018311
15.

Plasma copeptin and chronic kidney disease risk in 3 European cohorts from the general population.

El Boustany R, Tasevska I, Meijer E, Kieneker LM, Enhörning S, Lefèvre G, Mohammedi K, Marre M, Fumeron F, Balkau B, Bouby N, Bankir L, Bakker SJ, Roussel R, Melander O, Gansevoort RT, Velho G.

JCI Insight. 2018 Jul 12;3(13). pii: 121479. doi: 10.1172/jci.insight.121479. [Epub ahead of print]

16.

Glycosuria amount in response to hyperglycaemia and risk for diabetic kidney disease and related events in Type 1 diabetic patients.

Carpentier C, Dubois S, Mohammedi K, Belhatem N, Bouhanick B, Rohmer V, Briet C, Bumbu A, Hadjadj S, Roussel R, Potier L, Velho G, Marre M.

Nephrol Dial Transplant. 2018 Jul 5. doi: 10.1093/ndt/gfy197. [Epub ahead of print]

PMID:
29982607
17.

Jointly Modelling Single Nucleotide Polymorphisms With Longitudinal and Time-to-Event Trait: An Application to Type 2 Diabetes and Fasting Plasma Glucose.

Canouil M, Balkau B, Roussel R, Froguel P, Rocheleau G.

Front Genet. 2018 Jun 14;9:210. doi: 10.3389/fgene.2018.00210. eCollection 2018.

18.

Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study.

Sullivan SD, Bailey TS, Roussel R, Zhou FL, Bosnyak Z, Preblick R, Westerbacka J, Gupta RA, Blonde L.

Diabetes Obes Metab. 2018 Sep;20(9):2148-2158. doi: 10.1111/dom.13345. Epub 2018 Jun 25.

19.

A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study.

Ritzel R, Harris SB, Baron H, Florez H, Roussel R, Espinasse M, Muehlen-Bartmer I, Zhang N, Bertolini M, Brulle-Wohlhueter C, Munshi M, Bolli GB.

Diabetes Care. 2018 Aug;41(8):1672-1680. doi: 10.2337/dc18-0168. Epub 2018 Jun 12.

PMID:
29895556
20.

Associations of fats and carbohydrates with cardiovascular disease and mortality-PURE and simple?

Hansel B, Roussel R, Giral P.

Lancet. 2018 Apr 28;391(10131):1680. doi: 10.1016/S0140-6736(18)30752-9. Epub 2018 Apr 26. No abstract available.

PMID:
29726341
21.

Sex Difference In the Effect of Fetal Exposure to Maternal Diabetes on Insulin Secretion.

Gautier JF, Fetita LS, Riveline JP, Ibrahim F, Porcher R, Abi Khalil C, Velho G, Choukem SP, Hadjadj S, Larger E, Roussel R, Boudou P, Marre M, Ravussin E, Mauvais-Jarvis F.

J Endocr Soc. 2018 Mar 22;2(5):391-397. doi: 10.1210/js.2017-00482. eCollection 2018 May 1.

22.

Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300U/mL vs glargine 100U/mL in T2DM.

Roussel R, Ritzel R, Boëlle-Le Corfec E, Balkau B, Rosenstock J.

Diabetes Metab. 2018 Nov;44(5):402-409. doi: 10.1016/j.diabet.2018.02.002. Epub 2018 Feb 19.

23.

No prognostic role of a GWAS-derived genetic risk score in renal outcomes for patients from French cohorts with type 1 and type 2 diabetes.

Barbieux P, György B, Gand E, Saulnier PJ, Ducrocq G, Halimi JM, Feigerlova E, Hulin-Delmotte C, Llaty P, Montaigne D, Rigalleau V, Roussel R, Sosner P, Zaoui P, Ragot S, Marre M, Tregouët DA, Hadjadj S; SURDIAGENE Study Group; French JDRF Diabetic Nephropathy Collaborative Research Initiative (Search for genes determining time to onset of ESRD in T1D patients with proteinuria).

Diabetes Metab. 2018 Feb 10. pii: S1262-3636(18)30038-7. doi: 10.1016/j.diabet.2018.01.016. [Epub ahead of print] No abstract available.

PMID:
29540294
24.

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus.

Potier L, Chequer R, Roussel R, Mohammedi K, Sismail S, Hartemann A, Amouyal C, Marre M, Le Guludec D, Hyafil F.

Cardiovasc Diabetol. 2018 Jan 11;17(1):11. doi: 10.1186/s12933-017-0652-1.

25.

Non-severe hypoglycaemia is associated with weight gain in patients with type 1 diabetes: Results from the Diabetes Control and Complication Trial.

Bumbu A, Moutairou A, Matar O, Fumeron F, Velho G, Riveline JP, Gautier JF, Marre M, Roussel R, Potier L.

Diabetes Obes Metab. 2018 May;20(5):1289-1292. doi: 10.1111/dom.13197. Epub 2018 Jan 23.

PMID:
29272063
26.

Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans.

Enhörning S, Tasevska I, Roussel R, Bouby N, Persson M, Burri P, Bankir L, Melander O.

Eur J Nutr. 2017 Dec 14. doi: 10.1007/s00394-017-1595-8. [Epub ahead of print]

PMID:
29242971
27.

Plasma proprotein-convertase-subtilisin/kexin type 9 (PCSK9) and cardiovascular events in type 2 diabetes.

El Khoury P, Roussel R, Fumeron F, Abou-Khalil Y, Velho G, Mohammedi K, Jacob MP, Steg PG, Potier L, Ghaleb Y, Elbitar S, Ragot S, Andreata F, Caligiuri G, Hadjadj S, Boileau C, Marre M, Abifadel M, Varret M, Hansel B.

Diabetes Obes Metab. 2018 Apr;20(4):943-953. doi: 10.1111/dom.13181. Epub 2018 Jan 14.

PMID:
29205760
28.

Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.

Sanchez M, Roussel R, Hadjadj S, Moutairou A, Marre M, Velho G, Mohammedi K.

Diabetologia. 2018 Apr;61(4):977-984. doi: 10.1007/s00125-017-4510-1. Epub 2017 Nov 28.

PMID:
29185011
29.

Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes.

Bailey TS, Pettus J, Roussel R, Schmider W, Maroccia M, Nassr N, Klein O, Bolli GB, Dahmen R.

Diabetes Metab. 2018 Feb;44(1):15-21. doi: 10.1016/j.diabet.2017.10.001. Epub 2017 Nov 16.

30.

A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study).

Hansel B, Giral P, Gambotti L, Lafourcade A, Peres G, Filipecki C, Kadouch D, Hartemann A, Oppert JM, Bruckert E, Marre M, Bruneel A, Duchene E, Roussel R.

J Med Internet Res. 2017 Nov 8;19(11):e360. doi: 10.2196/jmir.7947.

31.

Genetically increased angiotensin I-converting enzyme alters peripheral and renal vascular reactivity to angiotensin II and bradykinin in mice.

Chollet C, Placier S, Chatziantoniou C, Hus-Citharel A, Caron N, Roussel R, Alhenc-Gelas F, Bouby N.

Am J Physiol Heart Circ Physiol. 2018 Feb 1;314(2):H350-H358. doi: 10.1152/ajpheart.00356.2017. Epub 2017 Nov 3.

32.

T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.

Nicolas A, Mohammedi K, Bastard JP, Fellahi S, Bellili-Muñoz N, Roussel R, Hadjadj S, Marre M, Velho G, Fumeron F.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2144. doi: 10.1093/ndt/gfx290. No abstract available.

PMID:
29048523
33.

The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.

Clark WF, Devuyst O, Roussel R.

J Intern Med. 2017 Oct;282(4):310-321. doi: 10.1111/joim.12654. Epub 2017 Sep 14. Review.

PMID:
28905441
34.

Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.

Wheeler E, Leong A, Liu CT, Hivert MF, Strawbridge RJ, Podmore C, Li M, Yao J, Sim X, Hong J, Chu AY, Zhang W, Wang X, Chen P, Maruthur NM, Porneala BC, Sharp SJ, Jia Y, Kabagambe EK, Chang LC, Chen WM, Elks CE, Evans DS, Fan Q, Giulianini F, Go MJ, Hottenga JJ, Hu Y, Jackson AU, Kanoni S, Kim YJ, Kleber ME, Ladenvall C, Lecoeur C, Lim SH, Lu Y, Mahajan A, Marzi C, Nalls MA, Navarro P, Nolte IM, Rose LM, Rybin DV, Sanna S, Shi Y, Stram DO, Takeuchi F, Tan SP, van der Most PJ, Van Vliet-Ostaptchouk JV, Wong A, Yengo L, Zhao W, Goel A, Martinez Larrad MT, Radke D, Salo P, Tanaka T, van Iperen EPA, Abecasis G, Afaq S, Alizadeh BZ, Bertoni AG, Bonnefond A, Böttcher Y, Bottinger EP, Campbell H, Carlson OD, Chen CH, Cho YS, Garvey WT, Gieger C, Goodarzi MO, Grallert H, Hamsten A, Hartman CA, Herder C, Hsiung CA, Huang J, Igase M, Isono M, Katsuya T, Khor CC, Kiess W, Kohara K, Kovacs P, Lee J, Lee WJ, Lehne B, Li H, Liu J, Lobbens S, Luan J, Lyssenko V, Meitinger T, Miki T, Miljkovic I, Moon S, Mulas A, Müller G, Müller-Nurasyid M, Nagaraja R, Nauck M, Pankow JS, Polasek O, Prokopenko I, Ramos PS, Rasmussen-Torvik L, Rathmann W, Rich SS, Robertson NR, Roden M, Roussel R, Rudan I, Scott RA, Scott WR, Sennblad B, Siscovick DS, Strauch K, Sun L, Swertz M, Tajuddin SM, Taylor KD, Teo YY, Tham YC, Tönjes A, Wareham NJ, Willemsen G, Wilsgaard T, Hingorani AD; EPIC-CVD Consortium; EPIC-InterAct Consortium; Lifelines Cohort Study, Egan J, Ferrucci L, Hovingh GK, Jula A, Kivimaki M, Kumari M, Njølstad I, Palmer CNA, Serrano Ríos M, Stumvoll M, Watkins H, Aung T, Blüher M, Boehnke M, Boomsma DI, Bornstein SR, Chambers JC, Chasman DI, Chen YI, Chen YT, Cheng CY, Cucca F, de Geus EJC, Deloukas P, Evans MK, Fornage M, Friedlander Y, Froguel P, Groop L, Gross MD, Harris TB, Hayward C, Heng CK, Ingelsson E, Kato N, Kim BJ, Koh WP, Kooner JS, Körner A, Kuh D, Kuusisto J, Laakso M, Lin X, Liu Y, Loos RJF, Magnusson PKE, März W, McCarthy MI, Oldehinkel AJ, Ong KK, Pedersen NL, Pereira MA, Peters A, Ridker PM, Sabanayagam C, Sale M, Saleheen D, Saltevo J, Schwarz PE, Sheu WHH, Snieder H, Spector TD, Tabara Y, Tuomilehto J, van Dam RM, Wilson JG, Wilson JF, Wolffenbuttel BHR, Wong TY, Wu JY, Yuan JM, Zonderman AB, Soranzo N, Guo X, Roberts DJ, Florez JC, Sladek R, Dupuis J, Morris AP, Tai ES, Selvin E, Rotter JI, Langenberg C, Barroso I, Meigs JB.

PLoS Med. 2017 Sep 12;14(9):e1002383. doi: 10.1371/journal.pmed.1002383. eCollection 2017 Sep.

35.

Association of impaired renal function with venous thrombosis: A genetic risk score approach.

Charmet R, van Hylckama Vlieg A, Germain M, Roussel R, Marre M, Debette S, Amouyel P, Deleuze JF, Hadjadj S, Rosendaal FR, Morange PE, Trégouët DA.

Thromb Res. 2017 Oct;158:102-107. doi: 10.1016/j.thromres.2017.08.015. Epub 2017 Aug 25.

PMID:
28866378
36.

Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes.

Ritzel R, Roussel R, Giaccari A, Vora J, Brulle-Wohlhueter C, Yki-Järvinen H.

Diabetes Obes Metab. 2018 Mar;20(3):541-548. doi: 10.1111/dom.13105. Epub 2017 Oct 5. Review.

37.

Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice.

Desposito D, Zadigue G, Taveau C, Adam C, Alhenc-Gelas F, Bouby N, Roussel R.

Sci Rep. 2017 Aug 25;7(1):9410. doi: 10.1038/s41598-017-09721-0.

38.

Transmission of Type 2 diabetes to sons and daughters: the D.E.S.I.R. cohort.

Balkau B, Roussel R, Wagner S, Tichet J, Froguel P, Fagherazzi G, Bonnet F; D.E.S.I.R. Study Group.

Diabet Med. 2017 Nov;34(11):1615-1622. doi: 10.1111/dme.13446. Epub 2017 Sep 3.

PMID:
28792638
39.

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (EDITION 1 and EDITION 2 subgroup analysis).

Roussel R, d'Emden MC, Fisher M, Ampudia-Blasco FJ, Stella P, Bizet F, Cali AMG, Wysham CH.

Diabetes Obes Metab. 2018 Feb;20(2):448-452. doi: 10.1111/dom.13071. Epub 2017 Sep 14.

40.

Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.

Roussel R, Steg PG, Mohammedi K, Marre M, Potier L.

Diabetes Obes Metab. 2018 Feb;20(2):238-244. doi: 10.1111/dom.13033. Epub 2017 Jul 25. Review.

PMID:
28597588
41.

Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis.

Paige E, Barrett J, Pennells L, Sweeting M, Willeit P, Di Angelantonio E, Gudnason V, Nordestgaard BG, Psaty BM, Goldbourt U, Best LG, Assmann G, Salonen JT, Nietert PJ, Verschuren WMM, Brunner EJ, Kronmal RA, Salomaa V, Bakker SJL, Dagenais GR, Sato S, Jansson JH, Willeit J, Onat A, de la Cámara AG, Roussel R, Völzke H, Dankner R, Tipping RW, Meade TW, Donfrancesco C, Kuller LH, Peters A, Gallacher J, Kromhout D, Iso H, Knuiman M, Casiglia E, Kavousi M, Palmieri L, Sundström J, Davis BR, Njølstad I, Couper D, Danesh J, Thompson SG, Wood A.

Am J Epidemiol. 2017 Oct 15;186(8):899-907. doi: 10.1093/aje/kwx149.

42.

Urinary lysophopholipids are increased in diabetic patients with nephropathy.

Saulnier-Blache JS, Feigerlova E, Halimi JM, Gourdy P, Roussel R, Guerci B, Dupuy A, Bertrand-Michel J, Bascands JL, Hadjadj S, Schanstra JP.

J Diabetes Complications. 2017 Jul;31(7):1103-1108. doi: 10.1016/j.jdiacomp.2017.04.024. Epub 2017 May 10.

PMID:
28506691
43.

T-cadherin gene variants are associated with nephropathy in subjects with type 1 diabetes.

Nicolas A, Mohammedi K, Bastard JP, Fellahi S, Bellili-Muñoz N, Roussel R, Hadjadj S, Marre M, Velho G, Fumeron F.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1987-1993. doi: 10.1093/ndt/gfx071.

PMID:
28499019
44.

Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes.

El Boustany R, Taveau C, Chollet C, Velho G, Bankir L, Alhenc-Gelas F, Roussel R, Bouby N.

J Diabetes Complications. 2017 Jun;31(6):929-932. doi: 10.1016/j.jdiacomp.2017.04.005. Epub 2017 Apr 6.

PMID:
28412033
45.

Vasopressin and diabetic nephropathy.

Roussel R, Velho G, Bankir L.

Curr Opin Nephrol Hypertens. 2017 Jul;26(4):311-318. doi: 10.1097/MNH.0000000000000335. Review.

PMID:
28403013
46.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk.

Potier L, Roussel R, Elbez Y, Marre M, Zeymer U, Reid CM, Ohman M, Eagle KA, Bhatt DL, Steg PG; REACH Registry Investigators*.

Heart. 2017 Sep;103(17):1339-1346. doi: 10.1136/heartjnl-2016-310705. Epub 2017 Mar 11.

PMID:
28285267
47.

Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population.

Saulnier PJ, Gand E, Ragot S, Bankir L, Piguel X, Fumeron F, Rigalleau V, Halimi JM, Marechaud R, Roussel R, Hadjadj S; SURDIAGENE Study group.

J Diabetes Res. 2017;2017:5327352. doi: 10.1155/2017/5327352. Epub 2017 Feb 1.

48.

Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans.

Wigger L, Cruciani-Guglielmacci C, Nicolas A, Denom J, Fernandez N, Fumeron F, Marques-Vidal P, Ktorza A, Kramer W, Schulte A, Le Stunff H, Liechti R, Xenarios I, Vollenweider P, Waeber G, Uphues I, Roussel R, Magnan C, Ibberson M, Thorens B.

Cell Rep. 2017 Feb 28;18(9):2269-2279. doi: 10.1016/j.celrep.2017.02.019.

49.

Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach.

Bonnefond A, Yengo L, Dechaume A, Canouil M, Castelain M, Roger E, Allegaert F, Caiazzo R, Raverdy V, Pigeyre M, Arredouani A, Borys JM, Lévy-Marchal C, Weill J, Roussel R, Balkau B, Marre M, Pattou F, Brousseau T, Froguel P.

BMC Med. 2017 Feb 23;15(1):37. doi: 10.1186/s12916-017-0784-x.

50.

Predicting severe hypoglycaemia with self-monitoring of blood glucose in type 1 diabetes.

Moutairou A, Roussel R, Charbonnel B, Leye A, Detournay B, Mohammedi K, Potier L.

Diabetes Metab. 2017 Sep;43(4):392-394. doi: 10.1016/j.diabet.2016.11.009. Epub 2017 Feb 1. No abstract available.

PMID:
28161368

Supplemental Content

Loading ...
Support Center